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Evidence has shown that hyperlipidemia is associated with retinoid dyshomeostasis. In liver, retinol is
mainly oxidized to retinal by retinol dehydrogenases (RDHs) and alcohol dehydrogenases (ADHs), further
converted to retinoic acid by retinal dehydrogenases (RALDHs). The aim of this study was to investigate
whether high-fat diet (HFD) induced hyperlipidemia affected activity and expression of hepatic
ADHs/RDHs andRALDHs in rats. Results showed that retinol levels in liver, kidneyand adipose tissue ofHFD
ratswere signiﬁcantly increased, while plasma retinol and hepatic retinal levels weremarkedly decreased.
HFD rats exhibited signiﬁcantly downregulated hepatic ADHs/RDHs activity and Adh1, Rdh10 and Dhrs9
expression. Oppositely, hepatic RALDHs activity and Raldh1 expression were upregulated in HFD rats. In
HepG2 cells, treatment of HFD rat serum inhibited ADHs/RDHs activity and induced RALDHs activity.
Among the tested abnormally altered components in HFD rat serum, cholesterol reduced ADHs/RDHs
activity and RDH10 expression, while induced RALDHs activity and RALDH1 expression in HepG2 cells.
Contrary to the effect of cholesterol, cholesterol-lowering agent pravastatin upregulated ADHs/RDHs ac-
tivity and RDH10 expression, while suppressed RALDHs activity and RALDH1 expression. In conclusion,
hyperlipidemia oppositely altered activity and expression of hepatic ADHs/RDHs and RALDHs, which is
partially due to the elevated cholesterol levels.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
The prevalence of obesity is becoming a threatening risk to
human health. Obesity, characterized by severe hyperlipidemia and
insulin resistance (1), is one of the potential risk factors of non-
insulin dependent diabetes mellitus (NIDDM). It is generally
accepted that obesity mainly results from the combined effects of
excess energy intake and reduced energy expenditure (2). In
addition to energy, dietary nutrients provide us essential vitamins
and other factors with regulatory roles. However, the effects of
individual micronutrients on the development of metabolic dis-
eases are not fully understood.
Vitamin A (retinol) is an essential fat-soluble micronutrient
involved in multiple crucial functions, such as vision, tissue dif-
ferentiation and immunity (3e5). The physiological functions ofx: þ86 25 83271060.
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).retinol are mainly mediated via its active metabolite, retinoic acid
(RA). RA regulates gene expression through activating nuclear re-
ceptors (6) including retinoic acid receptors (RAR) and retinoid X
receptors (RXR). Recent studies have shown that retinoids partici-
pate in glucose and lipid metabolism and adipogenesis via acti-
vating RAR and RXR (7e9).
Liver plays important roles in the homeostasis of vitamin A via
the transport, storage, production, and metabolism of retinoids
(10,11). In liver, the dietary retinol is ﬁrst oxidized to retinal by both
cytosolic alcohol dehydrogenases (ADHs) of the medium-chain
dehydrogenase/reductase superfamily and microsomal retinol de-
hydrogenases (RDHs) of the short-chain dehydrogenase/reductase
superfamily, subsequently oxidized to RA by retinal de-
hydrogenases (RALDHs). The conversion of retinal into RA is irre-
versible and considered to be the rate-limiting step in RA
biosynthesis (3,12,13). Some reports have demonstrated that he-
patic ADHs/RDHs and RALDHs play important roles in the main-
tenance of retinoid homeostasis (14e16), which indicates that the
alterations in activity of ADHs, RDHs and RALDHs may impact on
physiological functions via affecting RA formation. A report showednese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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while Raldh1-knockout mice were protected from diet-induced
obesity and insulin resistance (17). Treatment of retinal or
RALDHs inhibitor reduced fat deposit and increased insulin sensi-
tivity of ob/ob mice (17). Raldh1-knockout mice were reported to
exhibit attenuated gluconeogenesis and lower fasting glucose level,
which resulted from the downregulated expression of glucose-6-
phosphatase and phosphoenolpyruvate carboxykinase 1 (18).
Obesity is often associated with retinol disorder. Several clinical
investigations validate that obesity is frequently accompanied by
retinol inadequacy (19e22), which is considered to be associated
with the increased inﬂammatory response in obesity (23). As we
mentioned before, ADHs/RDHs and RALDHs play signiﬁcant roles in
the regulation of retinol levels. However, it remains unclear
whether obesity could change the expression and activity of he-
patic ADHs/RDHs and RALDHs and, in turn, lead to retinol disorder.
The aim of the study was: ﬁrstly to investigate whether dys-
homeostasis of retinoids occurred in rats with hyperlipidemia
induced by high-fat diet (HFD); secondly to investigate the effect of
hyperlipidemia on the activity and expression of hepatic ADHs/
RDHs and RALDHs; thirdly to identify components affecting ADHs/
RDHs and RALDHs activity in the serum of hyperlipidemia rats
using HepG2 cells as an in vitro model.
2. Material and methods
2.1. Chemicals and reagents
All-trans retinol, all-trans retinaldehyde, all-trans retinoic acid
(atRA), cholesterol, insulin, palmitic acid, oleic acid, stearic acid,
linoleic acid, O-Ethylhydroxylamine hydrochloride, b-Nicotinamide
adenine dinucleotide sodium salt (b-NAD), b-Nicotinamide adenine
dinucleotide phosphate sodium salt (b-NADP) and streptozotocin
(STZ) were purchased from Sigma Chemical Co. (St. Louis, MO, USA).
Bovine serum albumin (BSA) was purchased from Qcbio Science &
Technologies Co., Ltd. (Shanghai, China). 2-Nitrophenylhydrazine
hydrochloride (2-NPH$HCl) and 1-ethyl-3-(3-dimethylaminopropyl)
carbodiimide-hydrochloride (1-EDC$HCl) were purchased from J&K
Chemical, Ltd. (Beijing, China). All the other reagents were of analyt-
ical grade and were commercially available.
2.2. Animals and induction of hyperlipidemia rats
Male SpragueeDawley rats, weighing 100e110 g, were pur-
chased from SIPPR/BK Experimental Animal Co. Ltd. (Shanghai,
China). A total of 20 rats were employed in this study. The rats were
maintained under controlled conditions of temperature (22 ± 2 C)
and relative humidity (50 ± 10%) with 12-h lightedark cycle. They
were allowed free access to food and water. The study was
approved by Animal Ethics Committee of China Pharmaceutical
University (NO.CPU-PCPK-S1010354).
Hyperlipidemia rats were induced by feeding HFD according to
previous methods (24e27). The rats were acclimated for three days
before the experiment and divided randomly into normal control
(CON) group and HFD group. The HFD (Xietong, Nanjing, Jiangsu)
consisted of 15% lard (w/w), 5% sesame oil, 20% sucrose, 2.5%
cholesterol and 57.5% normal chow for 8 weeks. Both HFD and
normal chow contained standard vitamin A. One batch of rats
(n ¼ 5 for each group) were fed with HFD or normal chow for 8
weeks. During this period, blood samples were collected once a
week via the oculi chorioideae vein of rats under light ether
anesthesia after 6 h fasting, fasting blood glucose (FBG) concen-
tration was determined using a glucose reagent kit (Jiancheng
Biotech Co., Nanjing, China), body weight and energy intake were
recorded daily. On week 8, the experimental rats were fastedovernight and sacriﬁced under light ether anesthesia. Blood and
tissues (liver, adipose tissue, kidney) were immediately collected
for the determination of biochemical parameters and retinoid
concentration. Parts of liver were used for measuring biochemical
parameters and retinoid concentration. The remaining liver was
used for preparing hepatic microsomes and cytosol, assessing
levels of targeted gene mRNA. Insulin, triglyceride (TG), total
cholesterol (TC) and free fatty acids (FFA) were determined onweek
8. Plasma insulin was measured by iodine [125I] insulin RIA kit
(BNIBT Co., Beijing, China). Plasma and hepatic TG and TC levels
were measured by test kits (BHKT Clinical Reagent, Beijing, China)
using 10 ml plasma and 10% liver homogenate, respectively. The
concentrations of free palmitic acid, strearic acid, leinoleic acid and
oleic acid in plasma were assayed as their 2-nitrophenylhydrazine
derivatives by HPLC method previously described (28).
2.3. Retinol pharmacokinetics in experimental rats
Another batch of rats (n ¼ 5 for each group) were fed with HFD
or normal chow for 8 weeks. On week 8, these rats were fasted
overnight and were orally administrated retinol (intragastric
gavage 45 mg/kg, dissolved in olive oil) according to a previous
report (29). Blood samples (about 0.25 ml) were collected into
heparized tubes via the oculi chorioideae vein under light ether
anesthesia at 0, 1, 2, 3, 5, 7, 9, 12, 24 and 36 h post dose of retinol.
The plasma samples were stored at 80 C for retinoid analysis.
2.4. Activity of ADHs/RDHs and RALDHs in hepatic cytosol and
microsomes of rat
Hepatic cytosol and microsomes were prepared freshly from
experimental rats according to the method previously described
(30). The protein concentrations of the cytosol and microsomes
weremeasured by Bradfordmethod using BSA as the standard (31).
Activity of ADHs/RDHs and RALDHs in hepatic cytosol and mi-
crosomes were assessed according to previously described method
with minor modiﬁcations (32). Brieﬂy, hepatic ADHs/RDHs and
RALDHs activity was evaluated with retinal formation and all-trans
atRA formation in the presence of b-nicotinamide adenine dinu-
cleotide (b-NADþ) and b-Nicotinamide adenine dinucleotide
phosphate (b-NADPþ), respectively. The incubation mixture con-
sisted of hepatic cytosol/microsomes (at the ﬁnal concentration of
0.5 mg/ml), and a series concentrations of retinol or retinal, 4.0 mM
co-factor, 5 mM MgCl2, 91 mM butylated hydroxytoluene in a total
volume of 500 ml. The reaction was initiated by the addition of
retinol or retinal pre-incubated for 5 min at 37 C. Following 15min
incubation, the reaction was quenched by extraction with equal
volume of n-butanol/methanol, 95:5 (v:v) containing 0.005%
butylated hydroxytoluene. Organic phase was collected after
centrifugation and stored at 80 C for analyses (33).
2.5. Effect of hyperlipidemia rat serum on ADHs/RDHs and RALDHs
activity in HepG2 cells
The serum of experimental rats was inactivated by heating at
56 C for 30 min following ﬁltering through 0.22 -mm ﬁlter. HepG2
cells were treated with DMEM supplemented with 10% serum for
24 h (34). Brieﬂy, sub-conﬂuent (approximately 80%) HepG2 cells
were incubated with DMEM containing 10% serum from CON and
HFD rats for 24 h. Then, HepG2 cells were collected for the prepa-
ration of S9-mixtures according to the protocol previously
described (35,36). The ADHs/RDHs and RALDHs activity in S9-
mixtures was carried out according to the method described
above using NADþ as cofactor.
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hyperlipidemia rats on ADHs/RDHs and RALDHs activity in HepG2
cells
The effects of cholesterol and FFA on ADHs/RDHs and RALDHs
activity were examined in HepG2 cells. Brieﬂy, sub-conﬂuent
(approximately 80%) HepG2 cells were exposed to serum-free
DMEM containing different concentrations of cholesterol and FFA
(palmitic acid, strearic acid, leinoleic acid and oleic acid) for 24 h,
respectively. The incubated HepG2 cells were collected to isolate
total RNA and prepare S9 fraction. In order to readily dissolve FFA,
the preparation of FFA and BSA complex was made according to the
previously reported method (37). Effect of pravastatin on ADHs/
RDHs and RALDHs activity was also measured following incubation
with different levels of pravastatin.
2.7. Quantitative real time-PCR (qRT-PCR)
The mRNA levels of targeted genes in liver of experimental rats
and HepG2 cells were measured using qRT-PCR. Brieﬂy, total RNA
was isolated from rat liver tissues or HepG2 cells using Trizol
(SunShine Biotechnology, Nanjing, China) and converted to cDNA
using High Capacity cDNA Archive Kit (Life Technologies). Using the
cDNA as template, qRT-PCR was performed using ABI Prism 7500
Real Time PCR System and primers listed in Table 1. Melting curves
were performed to investigate the speciﬁcity of PCR reaction. The
gene expression levels were normalized to those of human b-ACTIN
or rat b-actin (2DDCt method).
2.8. Drug analysis
The determination of retinol concentration in plasma and tis-
sues was performed according to the method previously described
(38). The linear range of retinol was 0.25e8 mg/ml (r > 0.999) in
tissue homogenate and 0.05e1 mg/ml (r > 0.999) in plasma. Retinal
in liver homogenate was converted into a stable retinal (O-ethyl)
oxime derivative for accurate quantiﬁcation with a linear range of
3.125e100 ng/ml (r > 0.999) (39). The retinal and atRA in the in-
cubation experiment were measured according to previously re-
ported method (33,40). The linear range of retinal and atRA were
0.025e1 mg/ml (r > 0.999). Procedures of extracting retinoid from
plasma, tissues and incubation system were carried out in dark
room under red light to avoid retinoid degradation.
2.9. Data analysis and statistical analysis
The pharmacokinetic parameters were estimated using non-
compartmental analysis (Pheonix Winnonlin 6.1, Pharsight, St.Table 1
Primer sequences for qRT-PCR.
Gene Forward
Rat b-actin 50-GGGAAATCGTGCG
Raldh1 50-TCATTGAGAGTGGG
Rdh7 50-GG TCCCAATGAGT
Rdh2 50-GTCACATTATCATC
Dhrs9 50-AAGCAGTACCTCCT
Rdh10 50-CTTCCCTTCGAAGC
Adh1 50-ATTTCCTGCCCACA
Human b-ACTIN 50-AAGAGCTACGAGC
ADH1 50-AGTATCCGTACCAT
RALDH1 50-TGAATGATTTAGCA
RDH10 50-TTTCAAAGTGCTCT
RDH16 50-GGATTCTCCCTGTG
DHRS9 50-CTCTGTGGTTTTCTGLouis, MO, USA). Enzyme kinetic parameters were estimated using
Pheonix Winnonlin 6.1. The MichaeliseMenten equation (eq. (1))
was used to calculate apparent Km and Vmax values:
V ¼ Vmax$S
Km þ S (1)
where V is the velocity of formation of retinal or RA, S is the con-
centration of retinol or retinal in the incubationmixture, Vmax is the
maximum metabolic velocity, and Km is the MichaeliseMenten
constant.
Results were expressed as mean ± standard deviation (S.D.). 2-
way RM-ANOVA was performed to analyze statistical difference
of repeated measured data. The statistical difference between two
groups was determined by the Student's t-test. For statistical
testing among different treatment groups, one-way analysis of
variance test (ANOVA) was performed for multiple comparisons
followed by post-hoc StudenteNewmaneKeuls test. The 0.05 level
of probability was used as the criteria for signiﬁcance.
3. Results
3.1. Establishment of hyperlipidemia rats
Biochemical parameters were measured in plasma of CON rats
and HFD rats (Table 2). Compared with CON rats, HFD rats exhibited
signiﬁcantly higher levels of TG, TC and FFA. This was consistent
with our expectation that HFD rats showed higher body weight as
well as increased energy intake than CON rats, accompanied by
aberrantly increased liver weight, body fat (epididymal fat and
retroperitoneal fat) and hepatic lipid levels (Table 2), inferring the
occurrence of hyperlipidemia. No signiﬁcant change of FBG were
observed in HFD rats. Plasma insulin levels were elevated mildly in
HFD rats but without signiﬁcance.
3.2. Perturbation of retinoid homeostasis in HFD rats
Retinol concentrations were measured in plasma, liver, adipose
tissue and kidney of CON and HFD rats (Table 2). The results showed
that compared with CON rats, HFD signiﬁcantly lowered basal level
of retinol in plasma, but markedly elevated basal levels of retinol in
kidney, adipose tissue and liver. Contrast to the ﬁndings in the
change of retinol levels, HFD signiﬁcantly decreased basal retinal
levels in liver to 44% of CON rats.
To determine whether the decreased retinol level in plasma of
HFD rats came from alteration in its bioavailability, retinol con-
centrations in plasma of the experimental rats were measured
following oral administration of retinol (Fig. 1A). The resultsReverse
TGACATT-30 50-GCGGCAGTGGCCATCTC-30
AAGAAAGAAG-30 50-TCATCGGTCACATTGGAGAAG-30
GGATGAGA-30 50-GTAACCACCACCAAGGAGAGAC-30
AAACTTCCAG-30 50-TCCAATCCATTTAGCATTTTCAG-30
CTGTGAACC-30 50-CTTGGCATCCTTTCCAGCAG-30
AGTCGT-30 50-GGCACTCCGTACAAAAGCAC-30
GCGAAG-30 50-GACAATGACGCTTACACCGC-30
TGCCTGAC-30 50-TCCTGCTTGCTGATCCACAT-30
TCTGATGTT-30 50-CTTTGGAAAGCCCCCAAATGT-30
GGCTGCA-30 50-TGGCCACATACACCAATAGGTTC-30
GGGCGTTCGT-30 50-GCCCAGAGACCACACCAGCATTAT-30
GATCCTG-30 50-CAGGAACAGGTTCCCTCCTG-30
TGGACTCGTA-30 50-CCTTCCACTGCATATTTGGATGGA-30
Table 2
Alterations in physiological parameters, biochemical parameters and retinoid levels
in experimental rats.
Parameter CON HFD
Physiological parameter
Body weight (BW) (g) 354 ± 14 395 ± 23**
Epididymal fat (% of BW) 1.11 ± 0.14 1.58 ± 0.11**
Retroperitoneal fat (% of BW) 1.20 ± 0.21 1.85 ± 0.44*
Liver weight (% of BW) 2.94 ± 0.21 3.70 ± 0.21**
Energy intake (Kcal/rat/day) 41 ± 6 72 ± 4**
Biochemical parameter
Plasma glucose (mM) 6.84 ± 0.67 6.52 ± 1.07
Plasma insulin (mIU/l) 37.00 ± 8.11 45.80 ± 8.06
Plasma triglyceride (mM) 1.56 ± 0.36 2.85 ± 0.52**
Plasma total cholesterol (mM) 1.36 ± 0.19 1.63 ± 0.06*
Hepatic triglyceride (mmol/g) 11.21 ± 1.23 21.55 ± 4.86*
Hepatic total cholesterol (mmol/g) 4.18 ± 0.95 16.67 ± 1.18**
Plasma palmitic acid (g/l) 0.22 ± 0.05 0.26 ± 0.02
Plasma strearic acid (g/l) 0.11 ± 0.02 0.22 ± 0.03**
Plasma leinoleic acid (g/l) 0.18 ± 0.06 0.30 ± 0.04*
Plasma oleic acid (g/l) 0.29 ± 0.09 0.37 ± 0.03
Retinoid levels
Retinol in plasma (mg/ml) 0.43 ± 0.03 0.32 ± 0.03**
Retinol in liver (mg/g) 33.14 ± 3.62 44.90 ± 3.15*
Retinol in adipose tissue (mg/g) 0.68 ± 0.12 1.30 ± 0.14*
Retinol in kidney (mg/g) 1.77 ± 0.12 3.59 ± 0.43*
Retinal in liver (ng/g) 27.93 ± 1.13 12.16 ± 1.33*
n ¼ 5, mean ± S.D., *p < 0.05, **p < 0.01, Student's t-test vs. CON rats.
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CON rats, evidenced by signiﬁcantly shorter Tmax (3.0 ± 0.0 h for
HFD rats vs 5.8 ± 1.1 h for CON rats, p < 0.05, Student's t-test).
However, the plasma retinol concentration-time data showed no
signiﬁcant change between CON and HFD group (p ¼ 0.15, 2-way
RM-ANOVA). Retinol concentrations in plasma of all experimental
rats were almost declined to basal values at 24 h following oral dose
of retinol. The lower AUC0e24h was observed in HFD rats (Fig. 1C).
However, based on the fact that the basal retinol levels in plasma of
HFD rats were signiﬁcantly lower than those of CON rats, the
AUC0e24h and Cmax were corrected by individual basal levels. The
results showed that neither the corrected AUC0e24h nor the cor-
rected Cmax in plasma of HFD rats were affected by HFD feeding
(Fig. 1B, C).3.3. Attenuated activity and expression of ADHs and RDHs in liver
of HFD rats
ADHs and RDHs are mainly responsible for the oxidation of
retinol to retinal in cytosol and microsomes, respectively (11). The
activity of ADHs and RDHs in hepatic cytosol and microsomes wasFig. 1. Retinol levels and its exposure (described with Cmax, corrected Cmax, AUC0e24h and co
single oral administration of 45 mg/kg retinol. (A) Retinol levels in plasma of CON and HFD r
difference between groups was determined using 2-way RM-ANOVA). (B) Cmax, corrected C
concentration-time data. The corrected Cmax and AUC0e24h were corrected by individual basa
CON rat).measured in the presence of 4 mM NADþ or NADPþ (Fig. 2). It was
found that contribution of hepatic microsomes (RDHs) to retinol
metabolism was greater than that of cytosol (ADHs), evidenced by
higher Clint (Vmax/Km) of retinal formation in microsomes than in
cytosol (Table 3). Microsomal RDHs oxidized retinol to retinal using
NADþ or NADPþ as cofactor. Kinetic analysis showed that NADþ-
dependent RDH showed higher Vmax values, while NADPþ-depen-
dent RDH possessed 16-fold lower Kmvalue (Km, 5.3± 0.3 mmol/l for
NADPþ-dependent RDH vs 89.0 ± 1.0 mmol/l for NADþ-dependent
RDH), leading to a higher Clint of retinal formation in the presence
of NADPþ than that in the presence of NADþ, which indicated roles
of NADPþ-dependent RDHs in lower levels of retinol. ADHs also
metabolized retinol to retinal using both NADþ and NADPþ as co-
factor, but the contribution of NADþ-dependent ADHs was
greater than that of NADPþ-dependent ADHs (Table 3).
The activity of ADHs/RDHs in liver of HFD rats was simulta-
neously measured (Fig. 2AeD). The results showed that HFD
signiﬁcantly reduced NADþ-dependent ADHs activity (p < 0.01, 2-
way RM-ANOVA) and NADþ-dependent RDHs activity (p < 0.01,
2-way RM-ANOVA). Similarly, the analysis results of kinetic pa-
rameters showed that HFD decreased activity of NADþ-dependent
ADHs/RDHs in liver of rats (Table 3).
The mRNA levels of the enzymes which contribute to the he-
patic ADHs/RDHs activity were examined using qRT-PCR analysis.
Given the facts that microsomal RDH2, RDH7, RDH10 and DHRS9
contribute physiologically to atRA biosynthesis in rats (11) and
ADH1 was proposed to eliminate excess retinol to avoid retinol
toxicity (41), the mRNA levels of the ﬁve genes were measured
(Fig. 2E). The results demonstrated that HFD signiﬁcantly decreased
the expression of Adh1, Rdh10 and Dhrs9.3.4. Enhanced activity and expression of RALDHs in liver of HFD rats
Conversion of retinal to atRA is mainly catalyzed by RALDH1
that mainly accounts for the cytosolic RALDHs activity (42). The
RALDHs activity in hepatic cytosol and microsomes was measured
using atRA formation from retinal in an incubation system with
NADPþ or NADþ as cofactor (Fig. 3AeD). It was found that although
both hepatic microsomes and cytosol exhibited RALDHs activity in
the presence of NADPþ or NADþ, the contribution of hepatic mi-
crosomes to atRA formation was less than that of hepatic cytosol
(Table 4). Hepatic cytosol catalyzed the oxidation of retinal into
atRA with NADþ or NADPþ as cofactor, but the cytosolic RALDHs
activity preferred NADþ, evidenced by greater contribution of
NADþ-dependent atRA formation (Table 4).
It was also found that HFD signiﬁcantly enhanced cytosolic
RALDHs activity in the presence of NADþ (p < 0.01, 2-way RM-rrected AUC0e24h) in plasma of CON (open circle) and HFD (solid circle) rats following
ats following single administration of 45 mg/kg retinol (n ¼ 5, mean ± S.D., p values for
max, (C) AUC0e24h and corrected AUC0e24h observed or calculated from plasma retinol
l levels (n ¼ 5, mean ± S.D., *p < 0.05, N.S., no statistical signiﬁcance, Student's t-test vs.
Fig. 2. ADHs/RDHs activity and Adh1, Rdhs and Dhrs9 mRNA expression in the liver of CON (open circle) and HFD (solid circle) rats. Retinal formation from retinol in microsomes
with NADþ (A) or NADPþ (B) as cofactor; retinal formation from retinol in cytosol with NADþ (C) or NADPþ (D) as cofactor (n ¼ 5, mean ± S.D., p values for differences between
groups were determined using 2-way RM-ANOVA). (E) Hepatic mRNA expression of Adh1, Rdhs and Dhrs9 in CON and HFD rats (n ¼ 5, mean ± S.D., *p < 0.05, **p < 0.01, Student's t-
test vs. CON rat).
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analysis results of kinetic parameters in Table 4 showed that HFD
feeding signiﬁcantly up-regulated cytosolic RALDHs activity (1.7-
fold and 2-fold in the presence of NADþ and NADPþ, respec-
tively). This is in line with ﬁndings in activity of RALDH that HFD
feeding markedly up-regulated mRNA level of hepatic Raldh1
(Fig. 3E).Table 3
Kinetic parameters of hepatic ADHs/RDHs activity catalyzed by liver cytosol/mi-
crosomes with NAD/NADP as cofactor.
Enzyme Cofactor CON rats HFD rats
Microsomes NADþ Km (mM) 88.77 ± 3.32 99.56 ± 4.10**
Vmax (nmol/min/mg) 3.59 ± 0.16 2.80 ± 0.30**
Clint (ml/min/mg) 40.43 ± 0.56 28.10 ± 2.67**
NADPþ Km (mM) 5.32 ± 0.53 5.37 ± 1.46
Vmax (nmol/min/mg) 0.48 ± 0.04 0.48 ± 0.03
Clint (ml/min/mg) 90.11 ± 6.26 92.08 ± 17.39
Cytosol NADþ Km (mM) 109.49 ± 26.45 282.34 ± 66.76**
Vmax (nmol/min/mg) 0.76 ± 0.12 0.82 ± 0.03**
Clint (ml/min/mg) 7.16 ± 1.41 3.05 ± 0.76**
NADPþ Km (mM) 46.41 ± 22.09 53.46 ± 11.63
Vmax (nmol/min/mg) 0.10 ± 0.02 0.11 ± 0.02
Clint (ml/min/mg) 2.48 ± 0.95 2.14 ± 0.64
n ¼ 5, mean ± S.D, **p < 0.01, Student's t-test vs. CON rats.3.5. Effect of experimental rat serum on ADHs/RDHs and RALDHs
activity in HepG2 cells
ADHs/RDHs and RALDHs activity was measured using retinal
formation from retinol and atRA formation from retinal in HepG2
cells following 24 h incubationwith medium containing 10% serum
from experimental rats. Incubation with serum of HFD rats signif-
icantly inhibited ADHs/RDHs activity and enhanced RALDHs ac-
tivity (Fig. 4A, B), which was consistent with our in vivo data,
indicating that some abnormal components in the serum of HFD
rats affected ADHs/RDHs and RALDHs activity in hepatocytes.
3.6. Effects of the abnormally altered components in serum of HFD
rats on ADHs/RDHs and RALDHs activity in HepG2 cells
The present results showed that HFD rats exhibited abnormal
alterations in plasma levels of TG, TC and FFA. The effects of these
abnormally altered components on ADHs/RDHs and RALDHs activ-
ity in HepG2 cells were examined (Fig. 4C, D). It was found that only
cholesterol concentration-dependently inhibited ADHs/RDHs ac-
tivity and induced RALDHs activity. Treatment of 40 mg/ml choles-
terol decreased ADHs/RDHs activity to 22% of control cells (Fig. 4C),
and increased RALDHs activity to 123% of control cells (Fig. 4D). It
was also found that cholesterol reduced mRNA level of RDH10 and
increased that of RALDH1 in a concentration-dependent manner in
Fig. 3. RALDHs activity and Raldh1mRNA expression in the liver of CON (open circle) and HFD (solid circle) rats. Retinoic acid formation from retinal in microsomes with NADþ (A)
or NADPþ (B) as cofactor; retinoic acid formation from retinal in cytosol with NADþ (C) or NADPþ (D) as cofactor (n ¼ 5, mean ± S.D., p values for differences between groups were
determined using 2-way RM-ANOVA). (E) mRNA levels of Raldh1 in liver of experimental rats were determined by qRT-PCR (n ¼ 5, mean ± S.D., *p < 0.05, Student's t-test vs. CON
rat).
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in the regulation of ADHs/RDHs and RALDHs, effect of cholesterol-
lowering agent pravastatin on ADHs/RDHs and RALDHs was exam-
ined. Pravastatin (20mg/ml) downregulatedRALDHactivity to79%of
control cells (Fig. 4F),while upregulatedADHs/RDHsactivity to162%
of control cells (p ¼ 0.07) (Fig. 4G). Pravastatin treatment alsoTable 4
Kinetic parameters of hepatic RALDHs activity catalyzed by livermicrosomes/cytosol
with NAD/NADP as cofactor.
Enzyme Cofactor CON rats HFD rats
Microsomes NADþ Km (mM) 18.22 ± 4.25 16.60 ± 1.88
Vmax (pmol/min/mg) 24.00 ± 3.65 40.90 ± 8.53**
Clint (ml/min/mg) 1.38 ± 0.46 2.47 ± 0.43**
NADPþ Km (mM) 86.33 ± 29.96 35.43 ± 3.10**
Vmax (pmol/min/mg) 13.67 ± 3.27 12.92 ± 3.45
Clint (ml/min/mg) 0.17 ± 0.06 0.36 ± 0.09**
Cytosol NADþ Km (mM) 22.69 ± 5.67 24.24 ± 3.23
Vmax (nmol/min/mg) 0.18 ± 0.07 0.32 ± 0.04**
Clint (ml/min/mg) 7.74 ± 2.52 13.14 ± 2.03**
NADPþ Km (mM) 40.67 ± 6.83 35.70 ± 7.13
Vmax (nmol/min/mg) 0.11 ± 0.03 0.18 ± 0.04**
Clint (ml/min/mg) 2.72 ± 0.72 5.20 ± 1.21**
n ¼ 5, mean ± S.D, **p < 0.01, Student's t-test vs. CON rats.reduced mRNA level of RALDH1, while induced that of RDH10 in a
concentration-dependent manner in HepG2 cells (Fig. 4H).
Among the four tested FFA, only oleic acid inhibited ADHs/RDHs
activity in a concentration-dependent manner (Fig. 4C). Low levels
of oleic acid (0.05 mM) up-regulated RALDHs activity (Fig. 4D),
however, no concentration-dependent manner was found.
4. Discussion
In our present study, hyperlipidemia was induced by HFD
feeding to rats. The HFD rats exhibited increased body weight, liver
weight and fat composition, accompanied by elevated TC, TG and
FFA levels in plasma. All these alterations indicated the establish-
ment of hyperlipidemia and obesity. Besides these physiological
and biochemical alterations, the present study demonstrated that
HFD feeding decreased plasma retinol levels, but signiﬁcantly
increased retinol levels in tissues (liver, kidney and adipose tissue)
in rats. The decreased retinol levels in plasma of HFD rats were
consistent with observations in obese patients (19e21). In order to
determine whether the decreased basal retinol levels in plasma of
HFD rats came from the decrease in absorption of retinol, the
plasma exposures of retinol following oral dose of retinol were
measured. Contrast to our expectation, HFD rats exhibited faster
absorption, but neither the corrected Cmax nor the corrected
AUC0e24h was affected in HFD rats, inferring that the decreased
basal levels of retinol did not come from the decrease of retinol
Fig. 4. Effect of the abnormally altered components in serum of HFD rats on ADHs/RDHs and RALDHs activity in HepG2 cells. ADHs/RDHs activity (A) and RALDHs activity (B) were
determined after the treatment with the rats serum in HepG2 cells for 24 h (n ¼ 3, mean ± S.D., *p < 0.05, **p < 0.01, Student's t-test vs. control cells). ADHs/RDHs activity (C) and
RALDHs activity (D) were determined after the treatment with cholesterol (Cho), oleic acid (OA), palmitic acid (PA), strearic acid (SA) and leinoleic acid (LA) in HepG2 cells for 24 h.
(E) mRNA levels of ADH1, RDHs, DHRS9 and RALDH1 in HepG2 cells following 24 h treatment with cholesterol were determined by qRT-PCR. RALDHs activity (F) and ADHs/RDHs
activity (G) were determined after the treatment with pravastatin for 24 h. (H) mRNA levels of RALDH1 and RDH10 in HepG2 cells following 24 h treatment with pravastatin were
determined by qRT-PCR (n ¼ 3, mean ± S.D., *p < 0.05, **p < 0.01, One-way ANOVA vs. control cells).
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tissues, liver and kidney were signiﬁcantly increased. All these re-
sults indicated that the decreased retinol level in plasma of HFD rats
was partially attributed to the increased distribution of retinol to-
wards these tissues. Circulating retinol is mainly boundwith retinol
binding protein 4 (RBP4). RBP4 receptor-2 (RBPR2), a novel retinol
transporter was identiﬁed to potentially regulate retinol homeo-
stasis in liver and other tissues (43). The expression of RBPR2 in
adipose tissue can be signiﬁcantly induced by HFD feeding (43),
which may partly explain the increased distribution of retinol into
the peripheral tissues of HFD rats.
The enzymatic oxidation of retinoid contributes to the retinoid
homeostasis in the liver. Our present data demonstrated that
contribution of hepaticmicrosomes to retinol dehydrogenationwas
greater than that of cytosol. RDHs metabolized retinol using NADþ
or NADPþ as cofactor, but NADPþ-dependent RDHs showed higher
retinol afﬁnity, indicating roles of NADPþ-dependent RDHs in
retinol metabolism under physiological status. However, it was
found that HFD feeding only decreased activity of NADþ-dependent
ADHs/RDHs. Data from qRT-PCR analysis showed that HFD feeding
signiﬁcantly decreased mRNA levels of Adh1, Rdh10 and Drhs9,
inferring that the decreased cytosolic and microsomal ADHs/RDHs
activity in the liver of HFD rats was partially due to the down-
regulation of enzyme expression.The oxidation of retinal to RA was mediated by cytosolic
RALDHs. Contrast to the ﬁndings in ADHs and RDHs, HFD signiﬁ-
cantly induced hepatic RALDHs activity and Raldh1 mRNA levels,
which was consistent with reports in Zucker fatty rats (44). Both
inhibition of hepatic ADHs/RDHs activity and induction of hepatic
RALDHs activity under hyperlipidemia status partially elucidated
the decreased retinal levels in liver of hyperlipidemia rats. Ablation
of Raldh1, administration of retinal or RALDHs inhibitor was re-
ported to increase insulin sensitivity and decrease fasting glucose
concentration in mice (17,18). All these results inferred that the
induction of Raldh1 expression and activity as well as the decrease
of hepatic retinal levels by hyperlipidemia may contribute to the
development of diabetes.
Serum of experimental animals has been applied to investigate
the impact of pathological factors on in vitro cell models such as rat
embryos (45), human endothelial cells (46), rat brain microvessel
endothelial cells (47) and HepG2 cells (48). In this study, cell culture
media supplemented with 10% HFD rat serum signiﬁcantly reduced
ADHs/RDHs activity and markedly enhanced RALDHs activity in
HepG2 cells, indicating that abnormal alterations of serum com-
ponents under hyperlipidemia status contribute to the opposite
alterations of ADHs/RDHs and RALDHs activity. It is well known
that hyperlipidemia is often associated with abnormal alterations
in FFA and cholesterol. Our results demonstrated that only
M. Zhang et al. / Journal of Pharmacological Sciences 127 (2015) 430e438 437cholesterol inhibited ADHs/RDHs activity and induced RALDHs
activity in a concentration-dependent manner, which was in par-
allel with data obtained from HepG2 cells treated with serum of
rats. In accordance to enzymes activity, cholesterol concentration-
dependently induced the mRNA levels of RALDH1 and reduced
those of RDH10. Cholesterol-lowering agent pravastatin signiﬁ-
cantly downregulated RALDHs activity and RALDH1 mRNA levels,
while upregulated ADHs/RDHs activity and RDH10 mRNA levels,
further veriﬁed the role of cholesterol in the oppositely altered
ADHs/RDHs and RALDHs activity.
Among four kinds of tested FFA, only oleic acid exhibited
concentration-dependently inhibitory effect on ADHs/RDHs activ-
ity, low levels of oleic acid also induced RALDHs activity. Those
results suggested that increased level of cholesterol may be one of
the main reasons leading to the decrease in ADHs/RDHs activity
and increase in RALDHs activity under hyperlipidemia status, but
roles of oleic acid need further investigation.
In conclusion, the present study clearly demonstrated that HFD
feeding down-regulated ADHs/RDHs activity and up-regulated
RALDHs activity in liver of rats. The oppositely altered ADHs/
RDHs and RALDHs activity and expressionwere partially attributed
to the elevated cholesterol content.
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